Mediolanum International Funds Ltd Has $12.42 Million Stock Position in Mettler-Toledo International, Inc. $MTD

Mediolanum International Funds Ltd boosted its holdings in Mettler-Toledo International, Inc. (NYSE:MTDFree Report) by 36.8% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 9,951 shares of the medical instruments supplier’s stock after purchasing an additional 2,676 shares during the quarter. Mediolanum International Funds Ltd’s holdings in Mettler-Toledo International were worth $12,418,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Reflection Asset Management bought a new position in shares of Mettler-Toledo International during the 4th quarter worth approximately $26,000. Whipplewood Advisors LLC acquired a new stake in shares of Mettler-Toledo International during the 1st quarter worth approximately $25,000. Elyxium Wealth LLC bought a new stake in shares of Mettler-Toledo International in the 4th quarter valued at $29,000. DV Equities LLC acquired a new position in shares of Mettler-Toledo International during the 4th quarter valued at $40,000. Finally, Root Financial Partners LLC lifted its position in shares of Mettler-Toledo International by 45.5% during the 1st quarter. Root Financial Partners LLC now owns 32 shares of the medical instruments supplier’s stock valued at $40,000 after acquiring an additional 10 shares during the period. 95.07% of the stock is owned by institutional investors and hedge funds.

Mettler-Toledo International Stock Up 0.0%

Shares of MTD opened at $1,310.09 on Monday. Mettler-Toledo International, Inc. has a 12-month low of $1,023.05 and a 12-month high of $1,525.17. The business’s fifty day moving average is $1,182.01 and its 200 day moving average is $1,281.77. The stock has a market cap of $26.48 billion, a P/E ratio of 30.72, a P/E/G ratio of 2.74 and a beta of 1.24.

Mettler-Toledo International (NYSE:MTDGet Free Report) last posted its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $8.70 by $0.21. The business had revenue of $947.13 million during the quarter, compared to the consensus estimate of $943.14 million. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. Mettler-Toledo International’s revenue was up 7.2% compared to the same quarter last year. During the same quarter last year, the firm posted $8.19 EPS. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, analysts expect that Mettler-Toledo International, Inc. will post 46.63 EPS for the current year.

Analyst Ratings Changes

Several brokerages recently issued reports on MTD. Citigroup cut their target price on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research note on Friday, May 8th. Robert W. Baird dropped their price objective on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a report on Monday, May 11th. Stifel Nicolaus cut their price objective on shares of Mettler-Toledo International from $1,600.00 to $1,400.00 and set a “buy” rating on the stock in a research report on Monday, May 18th. Wolfe Research began coverage on Mettler-Toledo International in a research note on Tuesday, June 2nd. They issued a “peer perform” rating for the company. Finally, JPMorgan Chase & Co. decreased their target price on Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating for the company in a research report on Monday, May 11th. Six research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $1,408.55.

Check Out Our Latest Analysis on MTD

Mettler-Toledo International Profile

(Free Report)

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.

See Also

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTDFree Report).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.